Lior Magal - Homebiogas Director Sales
| HMGS Stock | ILA 72.40 0.30 0.41% |
Insider
Lior Magal is Director Sales of Homebiogas
| Phone | 972 77 930 0416 |
| Web | https://www.homebiogas.com |
Homebiogas Management Efficiency
The company has return on total asset (ROA) of (0.2627) % which means that it has lost $0.2627 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5295) %, meaning that it generated substantial loss on money invested by shareholders. Homebiogas' management efficiency ratios could be used to measure how well Homebiogas manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Yaakov Saban | IDI Insurance | 50 | |
| Jacob Haber | IDI Insurance | 55 | |
| Rav Bartov | IDI Insurance | 46 | |
| Lior Ditman | IDI Insurance | N/A | |
| Paul Mondell | Skyline Investments | N/A | |
| Oded Bloom | Oron Group Investments | 58 | |
| Noes Alon | Ram On Investments and | 48 | |
| Nir Kelner | Adgar Investments and | 46 | |
| Ran Leibovich | Adgar Investments and | 45 | |
| Eyal BenHaim | Bank Leumi Le Israel | 52 | |
| Zvi Rotenberg | Oron Group Investments | N/A | |
| Tal FrielMann | IDI Insurance | 51 | |
| Raja Dakkuri | Bank Leumi Le Israel | 52 | |
| Merav Peretz | IDI Insurance | 52 | |
| Yossi Efrati | IDI Insurance | 52 | |
| David Paulson | Bank Leumi Le Israel | 60 | |
| Udi Efron | Adgar Investments and | 49 | |
| Daniel Shapira | Oron Group Investments | 69 | |
| Avraham Ortal | Bank Leumi Le Israel | 56 | |
| Itay Kantrowitz | Adgar Investments and | 59 | |
| Ziv CPA | Bank Leumi Le Israel | 52 | |
Management Performance
| Return On Equity | -0.53 | |||
| Return On Asset | -0.26 |
Homebiogas Leadership Team
Elected by the shareholders, the Homebiogas' board of directors comprises two types of representatives: Homebiogas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Homebiogas. The board's role is to monitor Homebiogas' management team and ensure that shareholders' interests are well served. Homebiogas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Homebiogas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oshik Efrati, CEO Founder | ||
| Lior Magal, Director Sales | ||
| Shoham Zak, Chief Officer | ||
| Muli Lahav, VP Marketing |
Homebiogas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Homebiogas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.53 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (4.17) % | |||
| Current Valuation | 83.15 M | |||
| Shares Outstanding | 19.64 M | |||
| Shares Owned By Insiders | 21.06 % | |||
| Shares Owned By Institutions | 49.85 % | |||
| Price To Book | 1.92 X | |||
| Price To Sales | 41.73 X | |||
| Revenue | 3.15 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Homebiogas Stock
Homebiogas financial ratios help investors to determine whether Homebiogas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Homebiogas with respect to the benefits of owning Homebiogas security.